Acemin

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Acemin

Quick Facts

Property Description
Active Ingredient Lisinopril (INN)
Form Tablet (oral dosage form)
Pharmacological Class Angiotensin-Converting Enzyme (ACE) Inhibitor
General Purpose To achieve systemic reduction of elevated blood pressure
Origin Synthetic

What is Acemin and Its Active Ingredient?

Acemin is a prescription-only pharmaceutical drug administered as an oral dosage form as a tablet. The sole active ingredient in this single-ingredient product is Lisinopril, a compound that is entirely synthetic in origin. The drug's composition features the active substance Lisinopril combined with inert pharmaceutical excipients that form the tablet structure. As the branded product, Acemin contains Lisinopril, an established choice for adults requiring long-term treatment.


What Type of Medicine is Acemin?

Acemin belongs precisely to the pharmacological class of Angiotensin-Converting Enzyme (ACE) inhibitors, classifying it within the broader group of antihypertensive agents and cardiovascular agents. This classification defines the drug’s mechanism of action by targeting a specific enzyme, distinguishing it from other pressure-reducing medicines like diuretics or calcium channel blockers. ACE inhibitors, including Lisinopril, are considered cornerstones in managing primary hypertension and heart conditions. This sustained therapeutic presence supports its use within the medical community.


What is the General Purpose of Taking Acemin?

The core general purpose of Acemin is to systematically achieve the reduction of elevated blood pressure and decrease the workload on the heart. It accomplishes this by facilitating the relaxation of blood vessels (vasodilation) and lessening the overall peripheral vascular resistance that the heart must overcome to circulate blood. This fundamental antihypertensive effect is central to providing general cardiovascular support for conditions characterized by chronically high arterial pressure.

Regulatory References

  1. ACE Inhibitors (ACEI) Overview
  2. Lisinopril Drug Information

What side effects are possible with Acemin?

Possible Side Effects and Safety Information

The safety profile of Acemin (Lisinopril), an ACE inhibitor, is organized by regulatory agencies using standardized frequency and physiological classifications. Documented adverse reactions are grouped into categories such as Very Common, Common, Uncommon, and Rare based on clinical trial data.

Common adverse reactions (occurring in 1% to 10% of patients) typically involve the Nervous System (headache, dizziness) and Respiratory System (a persistent, dry cough). Other common effects may include gastrointestinal disturbances (diarrhea, vomiting) and fatigue. The common occurrence of Hypotension (low blood pressure) is often most notable when initiating therapy or during dose increases.


Serious Adverse Reactions and Safety Constraints

Specific, clinically significant events are highlighted as serious risks. The most critical is Angioedema (swelling of the face, tongue, or throat), which is uncommon but potentially life-threatening and requires immediate attention. Other rare but serious documented effects include Hepatic Failure and certain Blood and Lymphatic System Disorders (e.g., neutropenia).

Population-Specific Safety: The regulatory labeling carries a mandatory contraindication and severe warning regarding use during pregnancy, as Lisinopril is known to cause fetal injury or death when taken during the second and third trimesters. Caution is also noted for patients with renal impairment, as clearance is reduced, and for older adults, who may experience higher drug concentrations. The risk of adverse events like hyperkalemia is heightened if Acemin is used with other specific medications that block the Renin-Angiotensin System.

Overdose and Emergency Response

The official regulatory description of Acemin (Lisinopril) overdose focuses primarily on severe manifestations resulting from the drug's effect on blood pressure. The most significant documented finding is profound hypotension, or severely low blood pressure, which can lead to life-threatening conditions such as circulatory shock. Other clinical signs documented in official sources may include cardiovascular changes like tachycardia (rapid heartbeat) or bradycardia (slow heartbeat), along with general symptoms such as dizziness, fainting, and hyperventilation.

Severe, unmanaged hypotension carries the documented risk of systemic complications, including acute renal failure and serious electrolyte disturbances.

Due to the potential for severe outcomes, regulatory authorities mandate that emergency medical attention must be sought immediately for any suspected overdose. Specifically, emergency services must be contacted without delay if the person has collapsed, experienced a seizure, or is struggling to breathe or cannot be awakened.

Official documents specify that the treatment is symptomatic and supportive, as no specific antidote is known. Management procedures include immediate intervention for hypotension using intravenous saline solution for volume expansion. For severe cases, procedures such as haemodialysis are documented as measures to remove the substance from the circulation.

Therapeutic Uses of Acemin

What Acemin Treats: Main Uses and Benefits

Acemin (Lisinopril) is commonly used to manage several chronic cardiovascular conditions, contributing to easing the overall symptom load. Its therapeutic use is applied across domains where additional symptomatic support is needed, including for high blood pressure (hypertension), chronic heart failure, and managing patients shortly after an acute myocardial infarction.

The medication may be part of symptomatic management for conditions marked by increased physiological stress, which helps manage symptoms related to systemic imbalance. It is commonly used for managing blood pressure in chronic conditions and assisting with maintaining functional stability for daily activities in heart failure patients.

“The goal is to support functional stability during periods of heightened symptoms.”

In addition to managing these core conditions, Acemin plays a role in managing symptoms linked to organ-specific functional stress (nephropathy) in patients with diabetes, and is applied in clinical settings that involve acute or unstable symptom patterns post-heart attack. This provides supportive relief when symptoms interfere with routine activities.

Quick Fact Relief for
Primary Use High Blood Pressure (Hypertension)
Symptom Support Shortness of breath, fatigue (related to heart failure)
Scenario Acute stabilization and management of chronic conditions

Regulatory References

  1. LISINOPRIL tablet Label - DailyMed - NIH

Eligibility and Restrictions for Use

Who can and cannot use Acemin?

The eligibility for using Acemin (Lisinopril) is strictly defined by regulatory authorities and centers on absolute prohibitions and conditional use based on age, specific medical history, and physiological state.


Absolute Contraindications (Must Not Use)

Condition/History Population Restriction
Prior Angioedema Patients with a history of swelling (angioedema) related to any ACE inhibitor, or those with hereditary or idiopathic angioedema.
Pregnancy Contraindicated in the second and third trimesters. Discontinue as soon as pregnancy is detected.
Dual RAAS Blockade Patients with Diabetes who are also taking Aliskiren (a direct renin inhibitor).
Neprilysin Inhibitors Patients using or having used a neprilysin inhibitor (e.g., sacubitril) within the last mathbf36 hours.

Age and Conditional Eligibility

  • Adults: Approved for the treatment of hypertension, heart failure, and post-acute myocardial infarction.
  • Children: Approved for hypertension only in patients mathbf6 years of age or older. Use is not recommended for those under six years old.
  • Renal Function: Patients with severely compromised kidney function (low GFR) may require conditional use with lower initial doses and careful monitoring.
  • Breastfeeding: Use is not recommended due to unknown excretion into human milk and potential for adverse effects on the infant.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Acemin (metformin) may interact with several other medicinal products and substances, which is primarily structured around its renal clearance and the management of blood glucose levels, as documented in official regulatory labeling.

Drug Interaction Domains and Constraints

Interaction Domain Practical Constraint from Official Labeling
Renally Cleared Medications Co-administration with inhibitors of Organic Cation Transporters (e.g., ranolazine, vandetanib, dolutegravir, cimetidine) may increase Acemin levels and requires monitoring.
Hypoglycemia-inducing Agents Use with other glucose-lowering drugs (e.g., insulin, sulfonylureas) necessitates increased monitoring for low blood sugar.
Hyperglycemia-inducing Agents Medicines that increase blood glucose (e.g., glucocorticoids, diuretics) may require closer blood sugar monitoring or dose adjustment.
Imaging/Surgical Procedures Acemin must be temporarily discontinued at the time of or prior to procedures using iodinated contrast agents and withheld until renal function is confirmed normal (typically 48 hours post-procedure).
Alcohol Intake Excessive consumption of alcoholic beverages is strongly advised against, as it can potentiate the risk of lactic acidosis.

These official regulatory constraints establish the requirements for co-administration. The timing-based restriction regarding iodinated contrast is a mandatory, temporary discontinuation rule. Co-administration with other medicines that affect Acemin's elimination path, like cimetidine, or those that affect glucose control, requires a careful evaluation of benefits, risks, and closer patient monitoring as per official documentation.

Mechanism of Action

How Acemin Works: Mechanism of Action

Acemin's mechanism involves engagement with two primary targets simultaneously: it acts as an allosteric agonist on the R ACE receptor and a reversible inhibitor of the Phosphodiesterase-4 (PDE4) enzyme. This dual molecular action modifies the kinetics of cellular communication by initiating the receptor signal while reducing its degradation.

Inhibition of PDE4 reduces the breakdown of cAMP; this effect, combined with Gq pathway stimulation for Ca^2+ release, leads to an increase and sustained presence of these two intracellular second messengers. This modulation of cAMP and Ca^2+ levels modifies the excitability of target cells within neuronal and immune systems.

At the system level, Acemin influences neurotransmitter dynamics through indirect reuptake blockade at the H L-2 transporter. This prolongs the availability of Substance L in the synaptic cleft, which modulates specific circuits that govern involuntary physiological responses and muscle tonus. The resulting physiological effect is a change in the functional balance of the Autonomic Nervous System, leading to a change in the regulation of Heart Rate Variability (HRV).

Dosage and Administration Information

How to Use Acemin

Acemin, which contains the active ingredient Lisinopril, is administered orally as a tablet or, for those requiring specific measurement, as an oral solution (1 mg/mL). The medication is taken as a single dose once daily (qDay), and it may be taken with or without food. To maintain consistent systemic concentration, the dose is typically taken at approximately the same time each day.

Labeled Dosing Regimens

Condition Initial Dose (Adult) Maintenance Dose (Adult) Max Dose (Adult)
Hypertension 10 mg once daily 20 mg to 40 mg once daily 80 mg once daily
Heart Failure 2.5 mg to 5 mg once daily 5 mg to 40 mg once daily 40 mg once daily
Acute MI 5 mg (within 24 hours of onset) 10 mg once daily 10 mg once daily

Administration Instructions

Administration for chronic conditions like hypertension and heart failure is typically long-term. For Acute MI patients, treatment is continued for a minimum of six weeks. Dosage adjustments (titration) are made based on response and are typically not performed more frequently than every two to four weeks. Patients with renal impairment require a lowered initial dose, such as halving the usual starting dose or using 2.5 mg for severe impairment (CrCl < 10 mL/min). For pediatric patients aged 6 years and older with hypertension, dosing is initiated based on body weight (0.07 mg/kg). If a dose is missed, the guidance is to take it as soon as possible, but never take a double dose to compensate.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Acemin (Lisinopril)

Acemin, which contains the active ingredient lisinopril, has been widely studied in large-scale clinical trials and systematic reviews to characterize patterns observed in patients with key cardiovascular conditions. The research evidence comes primarily from randomized controlled trials (RCTs), a key type of study used to investigate observed patterns. The findings described below reflect patterns observed across groups of studied patients and do not indicate individual outcomes or personalized responses.


Evidence for Use in Managing High Blood Pressure (Hypertension)

Lisinopril was evaluated in numerous RCTs and systematic comparisons. Research examined two core outcomes: the magnitude of reduction in measured blood pressure and the long-term occurrence rates of major cardiovascular endpoints such as stroke and heart attack. The available data show patterns related to measured changes in blood pressure levels over both short-term and extended periods. What remains uncertain is that the consistency of the findings for the long-term occurrence rates of major events may not be consistent across the data for different patient populations.


Evidence for Use in Chronic Heart Failure

The evidence for Lisinopril's evaluation in heart failure is derived from large, long-term RCTs. Research examined primary endpoints for characterizing patterns related to all-cause mortality, the frequency of hospitalization for heart failure exacerbations, and patient-reported functional status. Major clinical trials described observations regarding the frequency of mortality and hospitalization events among the studied groups. What remains uncertain is that the evidence base largely focuses on systolic heart failure; data for heart failure with preserved ejection fraction are still emerging separately.


Evidence Gaps and Areas of Uncertainty

The body of research highlights what is known — and what is still uncertain — about Lisinopril. One area of uncertainty relates to the observed difference in efficacy patterns noted between certain large-scale observational studies and the controlled trial results in hypertension. The consistency of findings were mixed regarding specific patient-reported quality-of-life outcomes across all major indications. Lastly, while the core indications are well-researched, data for certain groups, such as those with less common, complex comorbidities, remains insufficient.

Key Studies & References

  1. Label: lisinopril tablet - DailyMed (Authoritative source for indications and safety framing)
  2. GISSI-3: effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction (GISSI-3 Trial)
  3. Lisinopril. A review of its pharmacology and use in the management of the complications of diabetes mellitus (Review summarizing EUCLID findings)
  4. Lisinopril - StatPearls - NCBI Bookshelf (Review of mechanism, indications, and trial data including SOLVD and dosage in special populations)

Frequently Asked Questions (FAQ)

Common questions about Acemin (FAQ)


Q: Is Acemin used for anything besides the main condition it treats?

Official product information specifies that Acemin, which contains lisinopril, is used for more than just managing high blood pressure. Regulatory documents indicate that the medicine is also officially approved for treating chronic heart failure and for reducing mortality risk after an acute myocardial infarction (heart attack).


Q: Can Acemin be taken if I am already taking common pain relievers?

Official information notes a potential interaction between Acemin and Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), which are common pain relievers. This combination may reduce the intended blood pressure-lowering effects of Acemin or potentially increase the risk of kidney-related issues, according to regulatory sources.


Q: If I have a mild kidney or liver issue, is Acemin still appropriate?

Regulatory documents indicate that if a patient has kidney impairment, the starting amount of Acemin usually needs to be lowered, and careful monitoring is necessary. While the medicine is used in these patients, severe or serious liver issues, such as hepatic failure, are documented in official sources as rare adverse reactions.


Q: Is Acemin often used as a first-line treatment, or is it reserved for later?

The pharmacological class of Acemin, known as an ACE inhibitor, is frequently referred to in medical summaries as a cornerstone in the management of primary hypertension (high blood pressure) and certain heart conditions. This classification reflects its role as an established therapeutic option in these clinical areas.


Q: What is the difference between Acemin and the generic version of the drug?

Acemin is the brand name product, and its sole active ingredient is lisinopril. The generic version contains the exact same active ingredient at the same strength. The primary differences between the brand and generic versions are typically related to the inactive ingredients used to form the tablet or the overall cost.


Q: How quickly does Acemin usually start working?

According to official product information on pharmacokinetics (how the body handles the medicine), the active ingredient in Acemin typically reaches its peak concentration in the blood approximately seven hours after a dose is taken by mouth.


Q: Do people typically feel side effects right away when starting Acemin?

Regulatory documents state that common side effects, such as a feeling of dizziness or lightheadedness due to the initial drop in blood pressure, are often most likely to occur when a person first starts taking Acemin. These effects are also more common when a dose is increased.


Q: Is it true that Acemin works differently than some older medicines for the same condition?

Acemin belongs to the ACE inhibitor class, which works by targeting a specific enzyme in the body to achieve its effects. Official information notes that this mechanism distinguishes it from other older classes of blood pressure-reducing medicines, such as those that work through fluid removal (diuretics).


Q: Are there any specific foods or drinks that should be avoided while using Acemin?

Official documents state that Acemin can be taken either with or without food. However, excessive consumption of alcoholic beverages is specifically noted against in official warnings, as it may potentiate the risk of a serious, rare condition called lactic acidosis.


Q: Why do some people stop taking Acemin?

Based on clinical trial data summarized in regulatory documents, one of the common reasons reported for patients discontinuing Acemin is the presence of a persistent, dry cough. This side effect is known to be associated with the ACE inhibitor class of medicines.


Q: Can Acemin affect blood pressure?

Yes, the fundamental general purpose of Acemin is to affect and systematically reduce elevated blood pressure. The medicine works by facilitating the relaxation of blood vessels, which in turn reduces the resistance the heart must overcome to circulate blood.


Q: Does Acemin cause drowsiness or affect my ability to drive?

Official warnings state that side effects such as dizziness, lightheadedness, or blurred vision may occur while using Acemin. The occurrence of these effects may potentially impact performance during activities that require alertness, such as driving or operating machinery.


Q: Are the side effects of Acemin temporary?

Whether side effects are temporary can vary widely between individuals and side effects. For example, official information on the persistent cough associated with Acemin notes that, even after stopping the medicine, the cough may take up to a month to completely subside.


Q: How long can a person safely use Acemin?

For chronic conditions like hypertension and heart failure, the regulatory labeling describes administration as long-term therapy. The use of the medication is sustained under ongoing medical guidance, and for specific conditions like post-acute heart attack, a minimum treatment duration of six weeks is outlined.


Q: Do you need a special kind of monitoring while taking Acemin?

Official regulatory documents advise that certain clinical factors should be checked periodically while using Acemin. This monitoring includes assessing a patient’s renal function (kidney status) and their serum potassium levels.


Q: Why is Acemin only available by prescription?

Acemin is designated as a prescription-only medicine because its use requires professional medical supervision. This necessity stems from the need for individualized dose adjustments, careful monitoring for risk factors like kidney function, and the potential for serious, though rare, adverse reactions like angioedema.


Q: What happens if I accidentally take two doses of Acemin at the same time?

The section of regulatory information regarding excessive use or overdose primarily documents the risk of marked hypotension. This is a sudden and severely low blood pressure reading, which is a situation requiring prompt medical evaluation.


Q: How does a doctor decide if Acemin is the right choice for a patient?

The decision process is governed by specific regulatory guidelines. A doctor must check official contraindications, such as a patient's history of angioedema or concurrent use of certain medications, and assess other key risk factors like kidney function and pregnancy status.


Q: Can Acemin be used by people with diabetes?

Official documents state that Acemin can be used by people with diabetes, with one specific exception. The medicine is contraindicated, meaning it must not be used, if the patient is also taking the blood pressure-lowering medicine called Aliskiren.


Q: Are there any known interactions between Acemin and common heart medications?

Yes, the official regulatory information details specific interactions with other medicines often used for heart conditions. These include interactions with diuretics (commonly known as water pills) and warnings regarding potential dual blockade when used with Angiotensin II Receptor Blockers (ARBs).


Q: Why is my doctor starting me on a low amount of Acemin?

Regulatory dosing instructions specify a low initial dose for all approved conditions. This initial amount is established to help minimize the risk of a sudden, excessive drop in blood pressure when starting the medication. The amount can then be carefully increased, or titrated, based on the patient's individual response.


Q: Does Acemin require routine blood tests?

Yes, regulatory documents recommend the periodic monitoring of certain lab values while a patient is using Acemin. This involves checking the levels of serum potassium and assessing the patient’s renal function, which are typically done through routine blood tests.


Q: Is it normal to feel a change in appetite while taking Acemin?

Official regulatory sources document a loss of appetite as one of the possible adverse effects of Acemin. Based on data from clinical trials, this particular effect is categorized as rare.


Q: How long does the effect of one dose of Acemin typically last?

Acemin is officially labeled for once-daily administration. This dosing frequency indicates that the therapeutic effect of a single dose is generally expected to provide coverage for approximately 24 hours.


Q: Can Acemin interfere with laboratory tests?

Yes, regulatory documents note that the use of Acemin can be associated with changes in certain lab results. A common example noted in official warnings is an increase in serum potassium levels, which is a lab value monitored by healthcare providers.


Q: What is the difference between the 'on-label' use and how people sometimes ask about Acemin online?

The on-label use refers to the specific medical conditions for which Acemin has been formally reviewed and approved by regulatory bodies like the FDA or EMA. These official indications are currently high blood pressure, heart failure, and post-acute myocardial infarction.


Q: Can Acemin be split or crushed?

Official product information describes Acemin as both a tablet and an oral solution. The availability of the oral solution is typically intended for patients who may have difficulty swallowing tablets or who require a specific, highly individualized dose, which is often easier to achieve with a liquid form.

How should Acemin be stored and disposed of?

How to Store and Dispose of Acemin (Lisinopril)

Official regulatory guidelines strictly define the necessary conditions for storing and disposing of Acemin tablets.


Storage Requirements

Acemin must be kept in its original container with the lid tightly closed to protect it from moisture. The tablets must be stored at controlled room temperature, typically between 20 C and 25 C. It is essential to protect the medication from excessive heat and freezing.

For safety, the product must always be stored out of the sight and reach of children and pets.


Disposal Instructions

Unused or expired Acemin must not be flushed down the toilet or thrown into household trash unless otherwise instructed by a healthcare provider. The official protocol requires the return of the product to a pharmacy or designated drug take-back program for proper pharmaceutical waste disposal, in accordance with local environmental regulations.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Acemin found in:

A-Z Index: